{"id":"W2224500197","doi":"10.1200/jco.2012.30.15_suppl.5001","title":"Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; Clinical endpoint; Internal medicine; Carboplatin; Urology; Maintenance therapy; Oncology; Randomization; PARP inhibitor; Randomized controlled trial; Surgery; Gastroenterology; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001352683,0.00131091,0.001986506,0.000435235,0.0004053703,0.001030017,0.0007876664,0.001287967,0.004569366],"category_scores_gemma":[0.001033451,0.0008095919,0.001510298,0.0005727155,0.0009111076,0.0009635419,0.0004189798,0.002475205,0.0008949175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008586216,"about_ca_system_score_gemma":0.001442641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009493545,"about_ca_topic_score_gemma":0.002496008,"domain_scores_codex":[0.999542,0.0002377257,0.00003652657,0.00008975793,0.00002814748,0.00006584414],"domain_scores_gemma":[0.9991683,0.0001689928,0.0001817415,0.00006709185,0.00003651511,0.0003773769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9348723,0.02442321,0.00228001,0.0005398447,0.0007741878,0.00009816342,0.0000791032,0.0004818488,0.007550485,0.00006272162,0.0008961789,0.02794202],"study_design_scores_gemma":[0.7623203,0.2299648,0.005012977,0.00002749899,0.0005569105,0.00009457272,0.00002636398,0.0004307826,0.0006779572,0.00007596335,0.0007956644,0.00001630035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929355,0.00239449,0.0003767138,0.0003609188,0.0001906146,0.002127697,0.0006967259,0.00007003289,0.0008472477],"genre_scores_gemma":[0.991873,0.001899521,0.0010658,0.0007220189,0.0003531564,0.001677227,0.001014889,0.00001708503,0.001377294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004569366,"threshold_uncertainty_score":0.01528603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1250187096871302,"score_gpt":0.4775891494285547,"score_spread":0.3525704397414244,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}